Ranitidine

ATC Code A02BA02

Ranitidine

Definition

A member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked.

Also known as N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine, RANITIDINE — per NCIT

Also identified as

Indications

Disease Relation Source
Duodenal ulcer may prevent MEDRT · Public domain (U.S. Government work)
Gastric ulcer may prevent MEDRT · Public domain (U.S. Government work)
Duodenal ulcer may treat MEDRT · Public domain (U.S. Government work)
Gastric ulcer may treat MEDRT · Public domain (U.S. Government work)
Gastroesophageal reflux disease may treat MEDRT · Public domain (U.S. Government work)
Peptic esophagitis may treat MEDRT · Public domain (U.S. Government work)
Zollinger-Ellison syndrome may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Alimentary part of gastrointestinal system may treat a disease of this organ DERIVED · CC BY 4.0
Esophagus may treat a disease of this organ DERIVED · CC BY 4.0
Intestine may treat a disease of this organ DERIVED · CC BY 4.0
Small intestine may treat a disease of this organ DERIVED · CC BY 4.0
Stomach may treat a disease of this organ DERIVED · CC BY 4.0
Upper digestive tract may treat a disease of this organ DERIVED · CC BY 4.0

6 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.